Novavax Says Vaccine Targeting Covid and Flu Shows Promising Results in Early Data

France Nouvelles Nouvelles

Novavax Says Vaccine Targeting Covid and Flu Shows Promising Results in Early Data
France Dernières Nouvelles,France Actualités
  • 📰 NBCDFW
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

Novavax plans to move forward with a phase two trial this year to confirm the dosing levels, and a phase three during the 2023 flu season at the earliest.

's shots, which rely on messenger RNA to turn human cells into factories that produce copies of the virus spike protein, inducing an immune response that fights Covid. The spike is the part of the virus that latches onto and invades human cells.

The vaccine also uses an adjuvant that contains an extract purified from the bark of a tree in South America, to induce a broader immune response. The adjuvant has been used in licensed vaccines against malaria and shingles. Novavax's stand-alone Covid shots consist of 5 micrograms of the spike copy and 50 micrograms of the adjuvant.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

NBCDFW /  🏆 288. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Moderna says its new 'bivalent' vaccine shows promise against COVID variantsModerna says its new 'bivalent' vaccine shows promise against COVID variantsThe company says this version targets both the original coronavirus and the beta variant, and appears to provide broader and longer-lasting protection against different strains, including omicron.
Lire la suite »

Moderna Says Its New ‘Bivalent’ Vaccine Shows Promise Against COVID-19 VariantsModerna Says Its New ‘Bivalent’ Vaccine Shows Promise Against COVID-19 VariantsThe company says this version targets both the original coronavirus and the beta variant, and appears to provide broader and longer-lasting protection against different strains, including omicron.
Lire la suite »

Moderna says its new 'bivalent' vaccine shows promise against COVID variantsModerna says its new 'bivalent' vaccine shows promise against COVID variantsThe company says this version targets both the original coronavirus and the beta variant, and appears to provide broader and longer-lasting protection against different strains, including omicron.
Lire la suite »

Mom warns of COVID-19 misinformation after she says she became anti-vaccine influencerMom warns of COVID-19 misinformation after she says she became anti-vaccine influencerHeather Simpson opens up to 'GMA' about becoming an anti-vaccine influencer and how she turned away from online groups she once considered supportive.
Lire la suite »

Moderna Says Redesigned Covid Vaccine Produced Stronger Immunity Against Omicron Than Current ShotsModerna Says Redesigned Covid Vaccine Produced Stronger Immunity Against Omicron Than Current ShotsA 50-microgram dose of Moderna's new vaccine doubled the antibodies against the omicron variant six months after administration.
Lire la suite »

Ukraine Says Phase Two of the War Has Begun as Russia Begins Offensive in the DonbasUkraine Says Phase Two of the War Has Begun as Russia Begins Offensive in the DonbasUkraine Says Phase Two of the War Has Begun as Russia Begins Offensive in the Donbas. Follow Our Live Updates
Lire la suite »



Render Time: 2025-03-13 15:49:17